Cytomegalic inclusion disease is a common complication in recipients of organ transplants. In renal transplant recipients, the disease involves the lungs more often than it does the gastrointestinal tract. We report on a recipient of a cadaveric kidney who had cytomegalic inclusion disease that involved both the upper and lower gastro-intestinal tract, and massive gastro-intestinal bleeding that was caused by a large colonic ulcer. Despite treatment with ganciclovir and cytomegalovirus-specific immunoglobulin, the patient died from subsequent complications.

Extensive tissue loss in a weight-bearing area of the foot almost invariably heralds limb loss. We report on a 74-year-old man with diabetes mellitus who had an ischaemic foot that was affected by prolonged pressure, which resulted in a necrotic heel. After two sessions of debridement, the calcaneum became exposed. Amputation was initially suggested but was refused by the patient. The foot was subsequently salvaged by staged operations. The first operation was a femoro-anterior tibial bypass using an autogenous saphenous vein to revascularise the foot. This was followed by debridement and attachment of a free subscapular flap to cover the defect 2 weeks later by a plastic surgeon. After 85 days of rehabilitation by physiotherapy and education of foot care by a podiatrist, the patient was discharged home and was able to walk with a walking-stick. This multidisciplinary approach avoided an almost certain below-knee amputation.

We describe a case of asymptomatic human parvovirus B19 infection during pregnancy that led to hydrops fetalis and foetal death. The diagnosis was confirmed by the presence of parvovirus B19-specific IgM antibodies in the maternal serum and the pathognomonic findings, which showed intranuclear eosinophilic viral inclusions and margination of chromatin in foetal cells of haemopoietic lineage. Details of clinical, virological, and histological findings are presented. Difficulties in confirming the diagnosis of parvovirus B19 infection in Hong Kong are discussed.

Primary hyperparathyroidism is increasingly being diagnosed subsequent to the detection of hypercalcaemia using multichannel auto-analyser screening. This paper provides a local picture of the clinical presentation and management of primary hyperparathyroidism. A retrospective review was conducted of 44 patients with primary hyperparathyroidism who were treated at the Queen Elizabeth Hospital between January 1987 and July 1996. Twenty-five (56.8%) of the patients were asymptomatic. Only three (6.8%) patients gave radiograms that had features indicating primary hyperparathyroidism; seven (15.9%) had renal stones. The patients underwent one or more of the following localisation procedures: computerised tomography, ultrasonography, thallium-technetium subtraction scanning, and technetium Tc 99m sestamibi scanning. The latter method was the most sensitive (64.3%). Ten adenomas that could not be localised by any of these procedures were successfully removed during surgery. Surgery was successful in 94.4% of cases and surgical outcome was comparable to that reported in the literature.

We report our experience of autologous epidermal transplantation for three patients with vitiligo. The vitiligo in two patients was stable whereas that in the third was active. Autologous epidermal transplantation using suction blister roofs from normally pigmented skin was performed following the failure to repigment skin using topical steroid and/or psoralen-ultraviolet A treatment. Grafts were well taken in all three patients. Satisfactory repigmentation was noted in the two patients who had stable vitiligo; there were no complications except for mild hyperpigmentation at the donor areas. For the patient who had active vitiligo, depigmentation of the graft and concomitant Koebner's phenomenon at the donor site were observed 3 weeks after the procedure. We conclude that autologous epidermal transplantation using the roofs of suction blisters is an excellent and safe repigmenting procedure for stable, localised vitiligo and that active disease precludes transplantation.